incidence of pancreatitis with semaglutide Semaglutide-Associated Acute in a Patient Type 2 Diabetes Mellitus: A Case Report Does Semaglutide Cause Pancreatitis?

Patients who are borderline diabetic, have significant excess fat or carry increased cardiovascular risk may need standard-dose GLP-1 therapy

Clinical studies have demonstrated that sustained weight reductiontypically achieved through caloric restriction and increased physical activitycan lead to favourable changes in lipid parameters, including reductions in total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides, alongside modest increases in high-density lipoprotein cholesterol (HDL-C)

Those who pay membership fees can also take coaching sessions with diet experts, for additional support

European Heart Journal - Cardiovascular Pharmacotherapy 10(4):296306 Ma X, Liu Z, Ilyas I, Little PJ, Kamato D, Sahebka A et al (2021) GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential

Research on GLP-1 receptor agonists like Ozempic and Wegovy concludes there is a risk for increased psychiatric symptoms

However, it is important to monitor the levels of the sex steroid hormones as well as DHEA-S during supplementation just like with too little DHEA, too much DHEA (and/or DHEA-S) can have its own set of distressing symptoms